                         SEQUENCE LISTING

<110>  Energesis Pharmaceuticals, Inc.
 
<120>  Methods and Compositions for Inducing Brown Adipogenesis

<130>  ENP.100XC1PCT

<150>  US 63/022,640
<151>  2020-05-11

<160>  9     

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  UCP1 FAM-MGB probe

<400>  1
tcaaggggtt ggtaccttcc                                                   20


<210>  2
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  sense primer

<400>  2
cactaacgaa ggaccaacgg                                                   20


<210>  3
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  antisense primer

<400>  3
ttccaggatc caagtcgcaa                                                   20


<210>  4
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Cyclophilin A NED-MGB probe

<400>  4
actgccaaga ctgagtggtt                                                   20


<210>  5
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  sense primer

<400>  5
caaatgctgg acccaacaca                                                   20


<210>  6
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  antisense primer

<400>  6
tcactttgcc aaacaccaca                                                   20


<210>  7
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  PPARgamma2 VIC-MGB probe

<400>  7
tcacaagaaa tgaccatggt tg                                                22


<210>  8
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  sense primer

<400>  8
agcgattcct tcactgatac ac                                                22


<210>  9
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  antisense primer

<400>  9
ccagaatggc atctctgtgt                                                   20


